A major advance in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently lost in various kinds of malignancies, resulting https://bookmarkworm.com/story21881053/nanobodies-reactivate-tumor-suppressor-p53-the-potential-approach-for-malignant-treatment